Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127430-16-000102
Filing Date
2016-02-11
Accepted
2016-02-11 16:10:53
Documents
1
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 5  
1 PRIMARY DOCUMENT edgar.xml 5 4555
  Complete submission text file 0001127430-16-000102.txt   6013
Mailing Address 10 FINDERNE AVENUE BUILDING 10 BRIDGEWATER NJ 08807
Business Address 10 FINDERNE AVENUE BUILDING 10 BRIDGEWATER NJ 08807 908-977-9900
INSMED Inc (Issuer) CIK: 0001104506 (see all company filings)

EIN.: 541972729 | State of Incorp.: VA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10 FINDERNE AVENUE BUILDING 10 BRIDGEWATER NJ 08807
Business Address
SHAROKY MELVIN MD (Reporting) CIK: 0001182633 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-30739 | Film No.: 161411614